Alnylam Pharmaceuticals' Profit After Tax rose 325.05% to $251.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.6 million, marking a year-over-year increase of 113.11%. This contributed to the annual value of -$278.2 million for FY2024, which is 36.82% up from last year.
According to the latest figures from FY2024, Alnylam Pharmaceuticals' Profit After Tax is -$278.2 million, which was up 36.82% from -$440.2 million recorded in FY2023.
Alnylam Pharmaceuticals' 5-year Profit After Tax high stood at -$278.2 million for FY2024, and its period low was -$1.1 billion during FY2022.
Over the past 3 years, Alnylam Pharmaceuticals' median Profit After Tax value was -$440.2 million (recorded in 2023), while the average stood at -$616.5 million.
Per our database at Business Quant, Alnylam Pharmaceuticals' Profit After Tax crashed by 32.64% in 2022 and then skyrocketed by 61.08% in 2023.
Yearly analysis of 5 years shows Alnylam Pharmaceuticals' Profit After Tax stood at -$858.3 million in 2020, then rose by 0.64% to -$852.8 million in 2021, then crashed by 32.64% to -$1.1 billion in 2022, then surged by 61.08% to -$440.2 million in 2023, then soared by 36.82% to -$278.2 million in 2024.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value